These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38547918)

  • 1. The Role of Myeloid Cells in Thromboinflammatory Disease.
    Noone D; Preston RJS; Rehill AM
    Semin Thromb Hemost; 2024 Oct; 50(7):998-1011. PubMed ID: 38547918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
    Zhu Y; Chen X; Liu X
    Front Immunol; 2022; 13():838011. PubMed ID: 35309344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunothrombosis and thromboinflammation in host defense and disease.
    Martinod K; Deppermann C
    Platelets; 2021 Apr; 32(3):314-324. PubMed ID: 32896192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunothrombosis and the molecular control of tissue factor by pyroptosis: prospects for new anticoagulants.
    Ryan TAJ; Preston RJS; O'Neill LAJ
    Biochem J; 2022 Mar; 479(6):731-750. PubMed ID: 35344028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboinflammation: From Atherosclerosis to COVID-19.
    Wagner DD; Heger LA
    Arterioscler Thromb Vasc Biol; 2022 Sep; 42(9):1103-1112. PubMed ID: 35861953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones.
    Ebeyer-Masotta M; Eichhorn T; Weiss R; Semak V; Lauková L; Fischer MB; Weber V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes.
    Meier A; Sakoulas G; Nizet V; Ulloa ER
    J Infect Dis; 2024 Aug; 230(2):514-521. PubMed ID: 38728418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C inhibits neutrophil extracellular trap formation
    Healy LD; Puy C; Fernández JA; Mitrugno A; Keshari RS; Taku NA; Chu TT; Xu X; Gruber A; Lupu F; Griffin JH; McCarty OJT
    J Biol Chem; 2017 May; 292(21):8616-8629. PubMed ID: 28408624
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Meyers S; Crescente M; Verhamme P; Martinod K
    Arterioscler Thromb Vasc Biol; 2022 Mar; 42(3):261-276. PubMed ID: 35109674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-Extracellular Traps, Cell-Free DNA, and Immunothrombosis in Companion Animals: A Review.
    Goggs R; Jeffery U; LeVine DN; Li RHL
    Vet Pathol; 2020 Jan; 57(1):6-23. PubMed ID: 31342866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and intervention of PAD4 in NETs in acute respiratory distress syndrome.
    Liu X; Li T; Chen H; Yuan L; Ao H
    Respir Res; 2024 Jan; 25(1):63. PubMed ID: 38291476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To Gain Insights into the Pathophysiological Mechanisms of the Thrombo-Inflammatory Process in the Atherosclerotic Plaque.
    Nappi F
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13.
    Yang J; Wu Z; Long Q; Huang J; Hong T; Liu W; Lin J
    Front Immunol; 2020; 11():610696. PubMed ID: 33343584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.
    Bautista-Becerril B; Campi-Caballero R; Sevilla-Fuentes S; Hernández-Regino LM; Hanono A; Flores-Bustamante A; González-Flores J; García-Ávila CA; Aquino-Gálvez A; Castillejos-López M; Juárez-Cisneros A; Camarena A
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34066385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.
    Iliadi V; Konstantinidou I; Aftzoglou K; Iliadis S; Konstantinidis TG; Tsigalou C
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
    Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
    J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated haemostasis in thrombo-inflammatory disease.
    Klavina PA; Leon G; Curtis AM; Preston RJS
    Clin Sci (Lond); 2022 Dec; 136(24):1809-1829. PubMed ID: 36524413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
    Skendros P; Mitsios A; Chrysanthopoulou A; Mastellos DC; Metallidis S; Rafailidis P; Ntinopoulou M; Sertaridou E; Tsironidou V; Tsigalou C; Tektonidou M; Konstantinidis T; Papagoras C; Mitroulis I; Germanidis G; Lambris JD; Ritis K
    J Clin Invest; 2020 Nov; 130(11):6151-6157. PubMed ID: 32759504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis.
    Cesta MC; Zippoli M; Marsiglia C; Gavioli EM; Cremonesi G; Khan A; Mantelli F; Allegretti M; Balk R
    Eur J Immunol; 2023 Jan; 53(1):e2250010. PubMed ID: 36239164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.